Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juha Okkeri
ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
PLoS ONE
Multidisciplinary
Related publications
Cancerous Inhibitor of Protein Phosphatase 2A Regulates Cisplatin Resistance in Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer After Colorectal Liver Metastasectomy
BMC Cancer
Cancer Research
Oncology
Genetics
Protein Phosphatase 2A Signaling in Human Prostate Cancer
Positive Regulation of Raf1-Mek1/2-Erk1/2 Signaling by Protein Serine/Threonine Phosphatase 2A Holoenzymes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Erlotinib Derivative Inhibits Hepatocellular Carcinoma by Targeting CIP2A to Reactivate Protein Phosphatase 2A
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
FAM122A, a New Endogenous Inhibitor of Protein Phosphatase 2A
Oncotarget
Oncology
Combination of EGFR and MEK1/2 Inhibitor Shows Synergistic Effects by Suppressing EGFR/HER3-dependent AKT Activation in Human Gastric Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
MicroRNA‑218 Inhibits the Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma Through Targeting Cancerous Inhibitor of Protein Phosphatase 2A
Oncology Letters
Cancer Research
Oncology
